第 8 届法布里病最新进展：2024 年法布里病的生物标志物、进展和治疗机会。

IF 2.3 4区医学 Q2 UROLOGY & NEPHROLOGY Nephron Pub Date : 2024-01-01 Epub Date: 2024-06-21 DOI:10.1159/000539834

引用次数: 0

摘要

法布里更新。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

8th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities in 2024.

Fabry Update.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nephron UROLOGY & NEPHROLOGY-

CiteScore

5.00

自引率

0.00%

发文量

期刊介绍： ''Nephron'' comprises three sections, which are each under the editorship of internationally recognized leaders and served by specialized Associate Editors. Apart from high-quality original research, ''Nephron'' publishes invited reviews/minireviews on up-to-date topics. Papers undergo an innovative and transparent peer review process encompassing a Presentation Report which assesses and summarizes the presentation of the paper in an unbiased and standardized way.

期刊最新文献

Sex Differences in Kidney Health and Disease. Myths, Realities and Pathways Forward -- A Patient's Thoughts on Person-Centred Care. Demand Analysis of Self-Management Mobile Health Applications for Middle-Aged and older Patients with Chronic Kidney Disease Based on the Kano Model. An Outbreak of Shiga Toxin-Positive Enteroaggregative Escherichia coli 0104:H4 Related Hemolytic Uremic Syndrome in Turkey: A Multicenter Study. NF-κB/miR-455-5p/SOCS3 axis aggravates sepsis induced acute kidney injury through promoting renal inflammation.